ADD4KIDS White Paper Paves the Way for Demand-Driven Paediatric Innovation in Europe

The ADD4KIDS consortium has released a white paper titled "Fostering Collaboration for Paediatric Demand-Driven Innovation: Insights and Strategies from the ADD4KIDS Working Groups." This document consolidates the expertise of healthcare providers, policymakers, patient associations, and innovation specialists to address challenges in paediatric innovation procurement.

The ADD4KIDS consortium has unveiled a comprehensive White Paper titled “Fostering Collaboration for Paediatric Demand-Driven Innovation: Insights and Strategies from the ADD4KIDS Working Groups”.

This report brings together the collective expertise of healthcare providers, policymakers, patient associations, and innovation specialists to address the unique challenges of paediatric innovation procurement.

Designed as an essential resource for all stakeholders in paediatric healthcare innovation, the paper provides actionable insights and strategic recommendations to shape the future of demand-driven innovation in this critical field.

Key Highlights of the White Paper

Identifying Unmet Needs: Employing innovative strategies to recognise and address pressing paediatric challenges.
Enhancing Stakeholder Engagement: Cultivating effective partnerships and promoting cross-border collaborations to strengthen the paediatric innovation ecosystem.
Implementing Value-Based Procurement: Integrating demand-driven instruments to facilitate sustainable and impactful changes in paediatric healthcare.

About ADD4KIDS

ADD4KIDS is a 12-month EU-funded initiative aimed at optimising the utilisation of demand-driven funding instruments, such as Procurement of Innovation (PPI) and Value-Based Procurement (VBP), to overcome barriers hindering the adoption of paediatric innovations across Europe. The project aspires to create a holistic action plan to ensure the seamless implementation of these instruments, thereby enhancing the competitiveness and innovation potential of the European paediatric sector.

ADD4KIDS Consortium Partners

Institut de Recerca Sant Joan de Déu – Fundació Sant Joan de Déu (FSJD-CERCA)
Barcelona Children’s Hospital Sant Joan de Déu (HSJD)
EIT Health
The Children’s Memorial Health Institute (IPCZD)
Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
SCIENSANO
The European Children’s Hospitals Organisation (ECHO)
Inveniam Group

This collaborative effort underscores the consortium’s commitment to transforming paediatric healthcare through strategic, demand-driven innovation.

Related News

Featured

i4KIDS joins CRAASH Barcelona Acceleration Programme to boost paediatric innovation

i4KIDS has joined the 8th edition of the CRAASH Barcelona programme, led by Biocat, as a new strategic partner. This collaboration reinforces the commitment to paediatric health innovation by ensuring the inclusion of at least one project in this field. The initiative complements i4KIDS’ recently launched acceleration programme, with both offering distinct yet complementary goals: while i4KIDS supports early-stage projects (TRL 2–4) through tailored valorisation, CRAASH Barcelona focuses on more advanced solutions (TRL 3–6) and their clinical and market validation.

Featured

i4KIDS opens the call for the Acceleration Programme 2025

i4KIDS has launched its Acceleration Programme 2025, a six-month initiative designed to support five early-stage projects (TRL 2–4) in the fields of paediatric and maternal health. Through tailored training, mentoring, and expert consultancy, the programme aims to help research groups and start-ups validate their solutions and prepare them for successful market entry.

Featured

i4KIDS Receives the National Award for Knowledge Transfer Promotion 2024

i4KIDS, the Paediatric Innovation Hub at Sant Joan de Déu Barcelona Children's Hospital, has been awarded the National Award for Knowledge Transfer Promotion 2024 by the Catalan Foundation for Research and Innovation (FCRI) and the Government of Catalonia. This prestigious recognition highlights i4KIDS' impact in advancing fetal, paediatric and maternal health innovation, fostering collaboration, and translating research into real-world healthcare solutions.